1. Lin C, Wang Y, Dong Y, Lai S, Wang L, Weng S, Zhang X. N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway. Biol Direct. 2022 Nov 17;17(1):33. doi: 10.1186/s13062-022-00347-5. PMID: 36397058; PMCID: PMC9673340.
2. Lai S, Wang Y, Li T, Dong Y, Lin Y, Wang L, Weng S, Zhang X, Lin C. N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancreatic cancer. Cell Biosci. 2022 Aug 8;12(1):125. doi: 10.1186/s13578-022-00844-0. PMID: 35941702; PMCID: PMC9361702.